REGENXBIO Inc. (Nasdaq: RGNX) today announced new positive interim data from the Phase I/II AFFINITY DUCHENNE trial. Updates ...

The collaboration will put together the MoxiePlex multiplex fluorescence technology with InSituPlex, Vizgen's proprietary sample preparation technique in which a mixture of antibodies are "barcoded" ...

Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for ...

Lung diseases encompass a diverse range of disorders, including Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), ...

Molecular Instruments® (MI), the inventor of the innovative HCRtm platform, and Alpenglow Biosciences, a leader in 3D light-sheet microscopy, are excited to announce a partnership that enables ...

Join 10,000+ vision professionals driving innovation in automation, AI and imaging with: Power-free contact lenses that ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

Varthur Road. In a major step forward to elevate the standards of surgical interventions, Manipal Hospital Varthur Road has ...